
Board Approves Decade of Innovation
The Board of Directors has unanimously approved our Decade of Innovation: Strategic Plan 2017. It will guide us as we grow and pioneer individualized medicine programs toward a vision of personalized healthcare.
The plan calls for National Jewish to recruit more than 100 new faculty and scientists, and grow annual research funding to $60 million. The essence of the plan is the true integration of our research, clinical, and educational efforts at the point of the patient.
Embracing this strategic plan will enable us to build on the outstanding history of the institution and extend our excellence as leaders in the research and treatment of respiratory, immune and related diseases.